For the study, researchers conducted a 12-week pilot clinical trial on 13 non-diabetic antiretroviral therapy treated people with HIV. The participants received metformin supplementation in addition to their antiretroviral therapy.
Researchers found that metformin increased the frequency of productively infected T cells expressing HIV proteins while preventing the virus from leaving the cells, noting this can help boost antiretrovirals.
As a result, metformin was shown to help reduce inflammation and improve immune system targeting of infected cells, according to the study.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.